Korean Co. Can't Be First To Invent CRISPR, PTAB Told
The Patent Trial and Appeal Board is again considering who was first to invent the CRISPR-Cas9 gene-editing technology, this time hearing arguments Monday from Korean biotechnology company ToolGen Inc. that it...To view the full article, register now.
Already a subscriber? Click here to view full article